DocBot (Medical Coding AI)

Irvine, California, United States  All United States companies → Founded 2013
Imaging AI Specialist Revenue Cycle / Billing Specialty-Focused AI
Series A — $8.5M

Products

DocBot (Medical Coding AI)
DocBot (Medical Coding AI)
Medical Billing & RCM
DocBot is a HIPAA-compliant AI assistant that helps physicians generate accurate diagnosis codes, avoid audits, and increase RAF scores by analyzing patient notes.

See all 1 product →

About DocBot (Medical Coding AI)

DocBot (Medical Coding AI) is an AI-powered medical coding assistant designed to help physicians generate accurate diagnosis codes, boost Risk Adjustment Factor (RAF) scores, and reduce audit risks. The platform utilizes natural language processing (NLP) and machine learning (ML) to analyze charts and clinical documentation, automatically identifying missed diagnoses, Hierarchical Condition Category (HCC) codes, and revenue opportunities.

This AI assistant aims to process complex medical data with high accuracy, typically achieving 95–98% coding accuracy, which surpasses traditional human reviewers. By identifying missed HCCs and documentation gaps, DocBot helps ensure a complete capture of patient complexity, leading to higher Medicare Advantage and Accountable Care Organization (ACO) reimbursements, potentially improving net revenue by 10–30% per patient annually.

Beyond retrospective analysis, DocBot AI can conduct real-time chart audits during patient encounters, suggesting diagnoses that providers might have overlooked and flagging documentation gaps before claim submission. It also automates compliant HCC coding to the highest level of specificity and is noted as the only publicly available ACA risk adjustment model online that shows ACA tiered risk across various plans.

Focus Areas

Gastrointestinal (GI) disease detection real-time image analysis polyp detection Barrett's Esophagus esophageal cancer stomach cancer inflammatory bowel disease (IBD) ulcerative colitis automated reporting clinical workflow automation AI-assisted endoscopy computer vision machine learning deep learning

Business Intelligence

Key InvestorsKhosla Ventures, Bold Capital Partners, Collaborative Fund, Y Combinator, Boutique Venture Partners, Lightbridge Ventures, Fenox Venture Capital, Scale Asia Ventures
PartnershipsEli Lilly
AcquisitionsAcquired by Satisfai Health, Inc. on November 21, 2022
TechnologyUltivisionAI software platform (AI, computer vision, machine learning, deep learning)

What Physicians Need to Know

Gastrointestinal (GI) Specialization
DocBot focuses exclusively on GI diseases, offering specialized AI for the detection of conditions such as polyps, Barrett's Esophagus, esophageal cancer, stomach cancer, inflammatory bowel disease (IBD), and ulcerative colitis. This deep domain expertise ensures highly relevant and accurate support for gastroenterologists.
Real-time AI-Assisted Endoscopy
Their core strength lies in real-time image analysis during endoscopic procedures. This includes immediate polyp detection and analysis, providing critical support to physicians during live examinations, which can significantly enhance diagnostic yield and procedural efficiency.
Advanced AI & Computer Vision
Leveraging cutting-edge computer vision, machine learning, and deep learning technologies, DocBot's AI models are trained to identify subtle anomalies and patterns in endoscopic images that might be challenging for the human eye, thereby improving diagnostic accuracy and consistency.
Clinical Workflow Automation
DocBot streamlines clinical operations through automated reporting and workflow automation. This reduces the administrative burden on physicians, allowing them to focus more on patient care rather than tedious documentation, and ensures consistent, high-quality reports.
Physician Tip

For physicians considering or using DocBot: n1. **Focus on Real-time Augmentation**: Leverage the real-time image analysis during endoscopy to augment your diagnostic capabilities, especially for subtle lesions or in challenging cases. n2. **Streamline Documentation**: Utilize the automated reporting features to reduce post-procedure administrative time, ensuring comprehensive and standardized reports. n3. **Enhance Training & Consistency**: Consider how DocBot's AI can serve as an educational tool for trainees or help standardize diagnostic approaches across a practice. n4. **Provide Feedback**: As with any AI tool, providing feedback on its performance in your specific clinical context can help refine and improve its accuracy over time. n5. **Integrate Thoughtfully**: Ensure seamless integration into your existing PACS and EHR systems to maximize workflow benefits and minimize disruption.

Effective integration with existing Electronic Health Record (EHR) systems, Picture Archiving and Communication Systems (PACS), and endoscopy equipment is crucial for DocBot to deliver its full value. Seamless data flow ensures that AI insights are readily available within the clinical workflow and that automated reports populate patient records accurately and efficiently.

Products by DocBot (Medical Coding AI)

1 product in the directory

DocBot (Medical Coding AI)
DocBot (Medical Coding AI)
Medical Billing & RCM
DocBot is a HIPAA-compliant AI assistant that helps physicians generate accurate diagnosis codes, avoid audits, and increase RAF scores by analyzing patient notes.

Reviews & Opinions

No web reviews on file yet for DocBot (Medical Coding AI). Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about DocBot (Medical Coding AI).

Loading videos...

Videos load interactively. If none appear, search YouTube for DocBot (Medical Coding AI) →

View all on YouTube

Press & Coverage

Business Wire
Docbot Closes Series A Financing Led by Khosla Ventures and Appoints Andrew J. Ritter as CEO
Docbot, an AI technology company focused on gastrointestinal disease, announced the closing of an oversubscribed $4 million Series A funding round led by Khosla Ventures, bringing its total raised to $8.5 million. The company also appointed Andrew J. Ritter as CEO, with co-founder Andrew Ninh transitioning to Chief Strategic Officer.
2021-05
Fierce Biotech
Gastrointestinal AI developer Docbot nets new CEO, series A funding for clinical trials
Docbot secured $4 million in Series A funding and a new CEO, Andrew Ritter, to advance clinical trials for its real-time AI programs designed to detect potential cancers during colonoscopies. The company's UltivisionAI platform aims to spot diseases across the entire GI tract.
2021-05
Mercom Capital Group
Docbot Raises $4 Million for Clinical Decision Support Platform
Docbot closed a $4 million Series A round, led by Khosla Ventures, for its UltivisionAI software platform, which uses AI for real-time computer vision and machine learning detection in GI disease. The new capital will be used to advance clinical trials and seek FDA clearance.
2021-05
Becker's ASC Review
Docbot raises $4M in series A funding, appoints new CEO
AI company Docbot announced a $4 million Series A funding round and the appointment of Andrew Ritter as CEO. The funding will support clinical trials and FDA clearance for its UltivisionAI device, which uses AI to detect gastrointestinal diseases.
2021-05
UCI Beall Applied Innovation
Docbot Exits Y Combinator, Receives $2.045M in Funding
Docbot, a UCI Applied Innovation startup, exited Y Combinator after securing $2.045 million in seed funding from investors including Khosla and BOLD Capital Partners. The funding will support clinical trials focused on real-time colon polyp detection and Barrett's Esophagus.
2019-05
International Journal for Research in Applied Science & Engineering Technology (IJRASET)
DocBot AI as Your Personal Health Assistant: Bridging the Gap in Consultations Revolutionizing Healthcare Using Natural Language Processing and Artificial Intelligence - IJRASET
This paper explores the DocBot Chat Bot/AI system as a novel solution for acquiring accurate and personalized health information, aiming to revolutionize healthcare information dissemination through AI algorithms and natural language processing. The system focuses on comprehensive health issue analysis and informed decision-making.
2024-09
ResearchGate
AI in Medical Coding: Transforming the US Healthcare System - ResearchGate
This paper analyzes the potential of AI and automation to transform medical coding, discussing underlying technologies like machine learning and natural language processing. It identifies significant positive outcomes, including reduced claim denial rates and increased coding throughput, while also addressing challenges like algorithmic bias and data privacy.
2025-09
ResearchGate
Medical Diagnosis and Treatment Recommendations (Doc-Bot) using Large Language Models - ResearchGate
This paper presents the development of a healthcare system, Doc-Bot, that combines machine learning with large language models like GPT-3 and GPT-4 to address various medical queries, predict diseases, and offer treatment recommendations. The system achieved 85% accuracy in preliminary diagnoses and 92% relevance in answering general medical queries.
2025-02

Frequently Asked Questions

DocBot leverages advanced computer vision and deep learning algorithms to analyze endoscopic images in real-time, identifying subtle anomalies indicative of GI diseases. This AI-assisted endoscopy helps physicians detect polyps, inflammation, and other suspicious lesions more consistently and efficiently during procedures.
DocBot's AI is trained to identify a range of critical GI conditions, including various types of polyps, early signs of Barrett's Esophagus, and suspicious areas potentially indicating esophageal or stomach cancer. Our system aims for high sensitivity and specificity, with detailed performance metrics available from our clinical validation studies.
DocBot is designed for seamless integration with most existing endoscopy systems and electronic health records (EHRs), minimizing disruption to current clinical workflows. It automates the generation of comprehensive procedure reports, including lesion characteristics, locations, and suggested coding, significantly reducing manual documentation time.
DocBot adheres to stringent regulatory compliance standards, including HIPAA for patient data privacy and security, and is pursuing necessary FDA clearance and CE Mark certification for medical device classification. We employ robust encryption, access controls, and de-identification protocols to safeguard all patient information.
DocBot offers flexible pricing models, typically subscription-based, tailored to the volume and specific needs of your practice or institution. We provide comprehensive onboarding, ongoing technical support, and dedicated training for physicians and clinical staff to ensure optimal utilization and integration of our AI solution.
Yes, DocBot's computer vision capabilities extend to identifying and quantifying markers of inflammation relevant to Inflammatory Bowel Disease (IBD), including Ulcerative Colitis. It can assist in assessing disease activity and extent, aiding physicians in more precise diagnosis and monitoring of treatment effectiveness.
DocBot is backed by strong investment and a dedicated team of AI and medical experts, ensuring long-term company stability and continuous innovation. We are committed to ongoing research and development, regularly releasing updates and new features, and actively seek strategic partnerships to expand our capabilities and reach within the healthcare ecosystem.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.